Experimental and Clinical Studies on the Antifibrinolytic and Presumed Antithrombotic Effect of a Kallikrein Inhibitor (Trasylol)

This publication has 19 references indexed in Scilit:

• Inhibition of Fibrinolytic and Thromboplastic Activity by Trasylol®
  Scandinavian Journal of Haematology, 1966
• Fibrinolyse und Blutverlust nach Prostata-Operationen und deren Beeinflußbarkeit durch Antifibrinolytika
  Deutsche Medizinische Wochenschrift (1946), 1966
• Experimental and Clinical Studies on AMCA, the Antifibrinolytically Active Isomer of p‐Aminomethyl Cyclohexane Carboxylic Acid
  Scandinavian Journal of Haematology, 1965
• Demonstration of Fibrinolytic Split Products in Human Serum by an Immunological Method in Spontaneous and Induced Fibrinolytic States
  Scandinavian Journal of Haematology, 1964
• Über die Wirkung von Proteinaseinhibitor-Präparaten (Leberund Parotisinhibitor) auf die extravasale Fibrinolyse, Fibrinogenolyse und Blutgerinnungskonstanten im Menschenblut
  Annals of Hematology, 1963
• A Method for Determining Serum Inhibitors of Plasminogen Activation
  Scandinavian Journal of Clinical and Laboratory Investigation, 1962
• Severe Thrombotic Disease in a Young Man with Bone Marrow and Skeletal Changes and with a High Content of an Inhibitor in the Fibrinolytic System
  Acta Medica Scandinavica, 1961
• Haemophilia in Sweden
  Acta Medica Scandinavica, 1961
• On an Inherited Autosomal Hemorrhagic Diathesis with Antihemophilic Globulin (AHG) Deficiency and Prolonged Bleeding Times¹
  Acta Medica Scandinavica, 1957
• The Separation of the Antibodies, Isoagglutinins, Prothrombin, Plasminogen and β₁-Lipoprotein into Subfractions of Human Plasma
  Journal of the American Chemical Society, 1949